Meningococcal Polysaccharide Vaccines

February 1976
Annals of Internal Medicine;Feb76, Vol. 84 Issue 2, p179
Academic Journal
Summarizes guidelines and recommendations by the Public Health Service Advisory Committee on Immunization Practices of the U.S. Department of Health, Education and Welfare concerning polysaccharide vaccines for meningococcal disease. Role of the antigens in the control of meningococcal disease epidemics; Overview of the vaccine usage; Background of the disease in the U.S.


Related Articles

  • Menveo Shown to Provide Immunogenicity.  // Drug Discovery & Development;Jan2008, Vol. 11 Issue 1, p36 

    The article announces that the Menveo vaccine from Novartis AG may protect infants using a schedule beginning at two months of age, against four of the most common causes of meningococcal disease.

  • No evidence for political manipulation... Moxon, E. Richard; Black, Steven // BMJ: British Medical Journal;5/10/2014, Vol. 348 Issue 7957, p23 

    A letter to the editor is presented in response to the article "Introducing a New Group B Meningococcus Vaccine" by D. I. Isaacs and J. McVernon, which appeared in the 2014 issue.

  • Introducing a new group B meningococcus vaccine. Isaacs, David; McVernon, Jodie // BMJ: British Medical Journal;4/5/2014, Vol. 348 Issue 7952, p9 

    The authors discuss the introduction of the new group B meningococcus vaccine Bexsero which is also known as 4CMenB, and which is developed using a genomic based reverse vaccinology approach. Particular focus is given to the introduction of 4CMenB vaccine in Great Britain to inform the rest of...

  • Vaccine-preventable infections in travellers abroad -- meningococcal disease. Willcox, Adrienne // Primary Health Care;Dec2010, Vol. 20 Issue 10, p33 

    This article offers an overview of the prevention of meningococcal infections in Great Britain. It highlights risks to British people who travel abroad. It discusses the need for vaccination to prevent the disease. In addition, the article advises travelers to understand how vaccines against...

  • Reducing mortality from emerging diseases.  // Weekly Epidemiological Record;3/27/2015, Vol. 90 Issue 13, p121 

    The article offers information on epidemic disease control and public health measures for reducing mortality from emerging diseases. It mentions two parameters that are taken into account for disease prevention and control including the transmission of the disease and its capacity to spread, and...

  • Meningococcal B disease: past, present and future. Willcox, Adrienne // Practice Nursing;Dec2011, Vol. 22 Issue 12, p650 

    No abstract available.

  • Men B to be added to childhood imms -- if price is right.  // Practice Nurse;4/18/2014, Vol. 44 Issue 4, p11 

    The article reports on the plans of Great Britain's Department of Health to include in the childhood vaccination programme Bexsero® vaccine, which was found by the Joint Committee on Vaccination and Immunisation(JCVI) to be effective in preventing meningococcal B (MenB) in infants. The...

  • Meningococcal Disease: Epidemiology and Early Effects of Immunization Programs. Sáfadi, Marco Aurelio P.; Berezin, Eitan N.; Arlant, Luiza Helena F. // Journal of the Pediatric Infectious Diseases Society;Jun2014, Vol. 3 Issue 2, p91 

    This article reports on the prevalence of Meningococcal disease and the effect of early immunization in selected countries like Brazil and Chile since they are reported to have a steady increase in cases. It states that early vaccination of the meningococcal C conjugate in Brazil granted a...

  • Meningococcal vaccines: WHO position paper, November 2011.  // Weekly Epidemiological Record;11/18/2011, Vol. 86 Issue 47, p521 

    The article presents information on meningococcal vaccines. Meningitis is caused by meningococcus (Neisseria meningitidis). It gets transmitted through respiratory droplets and stays in human nasopharynx. Though it occurs in small outbreaks, it can appear as epidemics in some regions like the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics